Long-term effects of psychedelic drugs: A systematic review

被引:126
|
作者
Aday, Jacob S. [1 ]
Mitzkovitz, Cayla M. [1 ]
Bloesch, Emily K. [1 ]
Davoli, Christopher C. [1 ]
Davis, Alan K. [2 ,3 ]
机构
[1] Cent Michigan Univ, Dept Psychol, 1200 S Franklin St, Mt Pleasant, MI 48859 USA
[2] Ohio State Univ, Coll Social Work, 1947 Coll Rd, Columbus, OH 43210 USA
[3] Johns Hopkins Sch Med, Ctr Psychedel & Consciousness Res, 5510 Nathan Shock Dr, Baltimore, MD 21224 USA
来源
关键词
Psychedelics; Psychedelic drugs; Long-term; Review; LYSERGIC-ACID DIETHYLAMIDE; PSILOCYBIN-ASSISTED PSYCHOTHERAPY; MYSTICAL-TYPE EXPERIENCES; LIFE-THREATENING CANCER; UNITED-STATES; LSD; PERSONALITY; DEPRESSION; ANXIETY; NEUROGENESIS;
D O I
10.1016/j.neubiorev.2020.03.017
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Research into the basic effects and therapeutic applications of psychedelic drugs has grown considerably in recent years. Yet, pressing questions remain regarding the substances' lasting effects. Although individual studies have begun monitoring sustained changes, no study to-date has synthesized this information. Therefore, this systematic review aims to fill this important gap in the literature by synthesizing results from 34 contemporary experimental studies which included classic psychedelics, human subjects, and follow-up latencies of at least two weeks. The bulk of this work was published in the last five years, with psilocybin being the most frequently administered drug. Enduring changes in personality/attitudes, depression, spirituality, anxiety, wellbeing, substance misuse, meditative practices, and mindfulness were documented. Mystical experiences, connectedness, emotional breakthrough, and increased neural entropy were related to these long-term changes in psychological functioning. Finally, with proper screening, preparation, supervision, and integration, limited aversive side effects were noted by study participants. Future researchers should focus on including larger and more diverse samples, lengthier longitudinal designs, stronger control conditions, and standardized dosages.
引用
收藏
页码:179 / 189
页数:11
相关论文
共 50 条
  • [1] Psychedelic experiences and long-term spiritual growth: a systematic review
    Schutt, William A.
    Exline, Julie J.
    Pait, Kathleen C.
    Wilt, Joshua A.
    CURRENT PSYCHOLOGY, 2024, 43 (32) : 26372 - 26394
  • [2] Systematic review of the long-term effects of postnatal corticosteroids
    Jenkinson, Allan C.
    Kaltsogianni, Ourania
    Dassios, Theodore
    Greenough, Anne
    JOURNAL OF PERINATAL MEDICINE, 2023, 51 (09) : 1120 - 1128
  • [3] Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports
    Yildirim, B.
    Sahin, S. S.
    Gee, A.
    Jauhar, S.
    Rucker, J.
    Salgado-Pineda, P.
    Pomarol-Clotet, E.
    McKenna, P.
    PSYCHOLOGICAL MEDICINE, 2024,
  • [4] EFFECTS OF PSYCHOTROPIC-DRUGS ON LONG-TERM ADJUSTMENT - A REVIEW
    GITTELMAN, RK
    KLEIN, DF
    POLLACK, M
    PSYCHOPHARMACOLOGIA, 1964, 5 (05): : 317 - 338
  • [5] The neurons that mediate a psychedelic's long-term antidepressive effects
    Shao, Ling-Xiao
    Kwan, Alex C.
    NATURE, 2025,
  • [6] Long-term effects of vertical bone augmentation: a systematic review
    Keestra, Johan Anton Jochum
    Barry, Obada
    de Jong, Lianne
    Wahl, Gerhard
    JOURNAL OF APPLIED ORAL SCIENCE, 2016, 24 (01) : 3 - 17
  • [7] Effects of prematurity on long-term renal health: a systematic review
    Sangla, Ananya
    Kandasamy, Yogavijayan
    BMJ OPEN, 2021, 11 (08):
  • [8] LONG-TERM EFFECTS OF NEUROLEPTIC DRUGS
    NIELSEN, IM
    CHRISTENSEN, AV
    JOURNAL DE PHARMACOLOGIE, 1975, 6 (03) : 277 - 282
  • [9] LONG-TERM EFFECTS OF NEUROLEPTIC DRUGS
    MOLLERNIELSEN, I
    CHRISTEN.AV
    JOURNAL DE PHARMACOLOGIE, 1974, 5 : 68 - 68
  • [10] Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans
    Carlos Bouso, Jose
    Palhano-Fontes, Fernanda
    Rodriguez-Fornells, Antoni
    Ribeiro, Sidarta
    Sanches, Rafael
    Crippa, Jose Alexandre S.
    Hallak, Jaime E. C.
    de Araujo, Draulio B.
    Riba, Jordi
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (04) : 483 - 492